These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1405215)

  • 1. [Limitation of adrenergic cardiovascular damage by exogenous infusion of a regulatory peptide dalargin].
    Pashutin SB
    Kardiologiia; 1992 Mar; 32(3):56-8. PubMed ID: 1405215
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cardiovascular effects of D-ALA2, LEU5, ARG6-enkephalin (dalargin) are mediated by peripheral mu-opioid receptor activation].
    Maslov LN; Lishmanov IuB; Barzakh EI; Maksimov IV; Vorozgtsova IN; Bukhovets IL; Minin SM; Orlova EB; Lavrov AG; Ovchinnikov MV
    Eksp Klin Farmakol; 2008; 71(2):21-8. PubMed ID: 18488902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The mechanism of the action of dalargin in experimental myocardial ischemia].
    Mikhaĭlova SD; Storozhakov GI; Bebiakova NA; Glushchenko NV; Semushkina TM
    Biull Eksp Biol Med; 1992 Oct; 114(10):345-7. PubMed ID: 1288681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of dalargin on the course of experimental cardiac arrhythmias].
    Grekova TI; Reznikov KM; Vinokurova OV; Kireeva AA; Taratinova TI; Nikolaevskiĭ VA; Shchetinkina NA
    Eksp Klin Farmakol; 1994; 57(2):24-6. PubMed ID: 8205043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of dalargin and des-Tyr-dalargin on the functional state of intact and ischemized-reperfused myocardium].
    Lasukova TV; Maslov LN; Lishmanov IuB; Ovchinnikov MV; Bespalova ZhD; Podoksenov IuK; Podoksenov AIu
    Eksp Klin Farmakol; 2004; 67(4):21-5. PubMed ID: 15500040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of the acute and chronic administration of dalargin to mongrel rats on cardiac chronotropism at rest and under physical loading].
    Sokolova NA; Kuligina LD; Ashmarin IP
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1991; (9):87-92. PubMed ID: 1751617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism of the protective effect of dalargin on development of ischemic heart arrhythmias].
    Mikhaĭlova SD; Storozhakov GI; Bebiakova NA; Semushkina TM
    Biull Eksp Biol Med; 1996 Aug; 122(8):176-8. PubMed ID: 9081471
    [No Abstract]   [Full Text] [Related]  

  • 8. [The mechanism of the antiarrhythmic action of dalargin in experimental myocardial ischemia].
    Maslov LN; Lishmanov IuB
    Eksp Klin Farmakol; 1992; 55(2):25-8. PubMed ID: 1358376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of enkephalins on the peripheral effects of adrenalin].
    Zoloev GK
    Fiziol Zh SSSR Im I M Sechenova; 1985 Oct; 71(10):1214-6. PubMed ID: 2998890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects leu-enkephalin and dalargin on the cardiac activity in rats during stimulation of postganglionic sympathetic fibers with low frequency impulses].
    Sitdikov FG; Makarenko TG
    Biull Eksp Biol Med; 1999 Feb; 127(2):140-3. PubMed ID: 10095939
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of pharmacological renal preconditioning with dalargin and lithium ions in the model of gentamycin-induced acute renal failure].
    Cherpakov RA; Grebenchikov OA; Plotnikov EJ; Likhvantsev VV
    Anesteziol Reanimatol; 2015; 60(1):58-63. PubMed ID: 26027228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Morphofunctional changes in the pancreas in response to dalargin under normal conditions and in experimental pancreatitis].
    Kurzanov AN; Titova GP; Vinogradov VA; Aleĭnik VA; Gerasimov NF
    Biull Eksp Biol Med; 1988 Apr; 105(4):445-7. PubMed ID: 3359026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The restriction of hemodynamic disorders in acute hypoxia and in situ reoxygenation by using the synthetic peptide bioregulator dalargin].
    Pashutin SB
    Biull Eksp Biol Med; 1991 Nov; 112(11):505-7. PubMed ID: 1810489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy in the cardiodepressive action of bacterial and toxic shock using the regulatory opioid peptide dalargin in rats].
    Pashutin SB
    Patol Fiziol Eksp Ter; 1991; (4):18-20. PubMed ID: 1798642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of the intravenous infusion of dalargin on biochemical and hormonal indices in the blood of patients with duodenal peptic ulcer].
    Sokolov AS; Dmitrieva OF; Tishchenko VA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):68-70. PubMed ID: 3801140
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antistress and cardioprotective properties of the synthetic analog of endogenous opioids dalargin in experimental burn trauma in rats].
    Pashutin SB
    Patol Fiziol Eksp Ter; 1992; (2):36-8. PubMed ID: 1408391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-arrhythmic effect of D-Ala 2, Leu 5, Arg 6-enkephalin and its possible mechanism.
    Maslov LN; Lishmanov YB
    Int J Cardiol; 1993 Jul; 40(2):89-94. PubMed ID: 8349385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A risk during an elective repair of craniosynostosis: the Cushing reflex.
    Erol DD
    Paediatr Anaesth; 2007 May; 17(5):496-7. PubMed ID: 17474960
    [No Abstract]   [Full Text] [Related]  

  • 19. A potential role for glucagon in the treatment of drug-induced symptomatic bradycardia.
    Love JN; Sachdeva DK; Bessman ES; Curtis LA; Howell JM
    Chest; 1998 Jul; 114(1):323-6. PubMed ID: 9674488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics of dalargin].
    Kalenikova EI; Dmitrieva OF; Korobov NV; Zhukovskiĭ SV; Tishchenko VA
    Vopr Med Khim; 1988; 34(1):75-83. PubMed ID: 3369130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.